Home000627 • SHE
add
Hubei Biocause Pharmaceutical Co. Ltd.
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.54B | — |
Operating expense | 874.53M | — |
Net income | 31.92M | — |
Net profit margin | 0.70 | — |
Earnings per share | — | — |
EBITDA | -152.96M | — |
Effective tax rate | 56.66% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.77B | — |
Total assets | 285.15B | — |
Total liabilities | 249.15B | — |
Total equity | 36.00B | — |
Shares outstanding | 4.94B | — |
Price to book | 0.36 | — |
Return on assets | -0.16% | — |
Return on capital | -0.86% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 31.92M | — |
Cash from operations | -192.16M | — |
Cash from investing | -3.29B | — |
Cash from financing | 813.10M | — |
Net change in cash | -2.68B | — |
Free cash flow | -3.39B | — |
About
Founded
Nov 18, 1993
Website
Employees
1,765
